Entrée Capital
VC Fund
London, United Kingdom
Entrée Capital is a VC fund in London focused on Software and FinTech. We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves. We back founders with a partnership built on trust, fairness and real operating experience. We stand with founders through every challenge, and help them grow with clarity, resilience and purpose.
- Total investments:
- 312
- Last investment:
- Lead investor:
- 34%
- Fund size:
- $175M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Entrée Capital invests in
Stages Entrée Capital invests in
Countries Entrée Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Seed
- $1.5M–$16M
- Series A
- $5.4M–$30M
- Series B
- $17M–$54M
Investment Focus
Industry
- Software 52 (17%)
- FinTech 28 (9%)
- Financial Services 24 (8%)
- Information Technology 24 (8%)
- Artificial Intelligence 22 (7%)
Stage
- Seed 103 (33%)
- Series A 80 (26%)
- Series B 40 (13%)
- Series C 20 (6%)
- Pre-Seed 19 (6%)
Country
- Israel 60 (19%)
- United States 59 (19%)
- United Kingdom 21 (7%)
- Germany 5 (2%)
- Nigeria 5 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adi Gozes
Partner
|
Partner | Total investments: 2 | Find email | |
Amit Goldenberg
Partner
|
Partner | Total investments: 0 | Find email | |
Aviad Eyal
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 82 | Find email | |
Eran Bielski
General Partner
|
General Partner | Total investments: 26 | Find email | |
Gideon Valkin
Board Member/Investor
|
Board Member/Investor | Total investments: 3 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs. | $18M / Seed / Oct 12, 2026 | ||
| Chamelio is a legal firm that offers contract review, contract negotiations, legal workflow, and contract management services. | $26M / Series A / Sep 22, 2026 | ||
| SaaS Practice Management Software for Dental Practices | $50M / Series C / Sep 11, 2026 | ||
| Lasso Security provides cybersecurity software for protecting artificial intelligence agents and applications across their lifecycle. | $30M / Seed / Sep 02, 2026 | ||
| Catch is the trusted AI Executive Assistant that actually gets work done. | $5M / Seed / Sep 02, 2026 | ||
| Easy Aerial is a leading provider of autonomous drone-based monitoring solutions for commercial, government, and military applications. Developed and manufactured in the United States, Easy Aerial’s free-flight and tethered drone-in-a-box systems are fully autonomous, modular, portable, and rugged, with the ability to operate in the most adverseweather conditions. They can be deployed anywhere for a multitude of mission-critical applications such as perimeter and border security, event monitoring, first responder, agriculture monitoring and industrial inspection, without needing a human operator. The company’s customer base includes military, government, aerospace, and commercial organizations in North America, Europe, Africa, and Asia. Easy Aerial was founded in 2015 and is headquartered in Brooklyn, New York, with regional offices in Tel-Aviv, Israel, and Belgrade, Serbia. Learn more by visiting us at www.easyaerial.com | $20M / Series B / Aug 31, 2026 | ||
| Horizon is developing an agentic interface for systematic trading. | $2M / Pre-Seed / Jul 16, 2026 | ||
| Alta leverages data and AI to drive business growth 24/7. | $25M / Series A / Jul 08, 2026 | ||
| Subterranean warfare for allied supremacy. | $25M / Seed / Jun 16, 2026 | ||
| PointFive provides a cloud and AI efficiency platform that helps organizations identify, monitor, and remediate inefficiencies across cloud infrastructure, data platforms, and AI environments. Its technology uses deep detection capabilities to uncover optimization opportunities that may be overlooked by traditional cloud cost management tools,while providing context and remediation workflows for engineering teams. The platform integrates with existing cloud environments and productivity tools, enabling teams to manage efficiency within their regular operational processes. PointFive supports multi-cloud environments and offers visibility into cloud usage, resource allocation, infrastructure performance, and AI-related spending across major cloud providers. By combining continuous monitoring, cost analysis, and automated remediation capabilities, the company helps organizations improve operational efficiency and manage cloud and AI expenditures more effectively. | $60M / Series B / Jun 08, 2026 | ||
| See all 312 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Entrée Capital invest in?
Entrée Capital invests primarily in Software, FinTech and Financial Services startups, most often at Seed and Series A stage. Most of the 312 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Entrée Capital invest in?
Entrée Capital typically joins rounds of $1.5M–$16M at Seed, $5.4M–$30M at Series A and $17M–$54M at Series B. These are whole funding-round sizes, not Entrée Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Entrée Capital took part in.
How do I contact Entrée Capital?
Public channels for Entrée Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Entrée Capital?
The team at Entrée Capital includes Adi Gozes (Partner), Amit Goldenberg (Partner) and Aviad Eyal (Co-Founder & Managing Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
